Top

POSTER AREA




Does the wedge hepatic vein pressure estimates portal pressure in patients with nash cirrhosis?

1 - Does the wedge hepatic vein pressure estimates portal pressure in patients with nash cirrhosis?


Ferrusquía-Acosta J, Bassegoda O, Turco L, Reverter E, GarcíaPagán JC, Graupera I, Sepchis F, Senzolo M, Hernández-Gea V

HPVG AS A GOLD STANDARD

Test- retest reliability of hepatic venous pressure gradient (hpvg): a study in 289 patients from the placebo group from 20 rct's

2 - Test- retest reliability of hepatic venous pressure gradient (hpvg): a study in 289 patients from the placebo group from 20 rct's


Wayne BAI, Mustafa AL-KARAGHOULI, Jesse STACH and Juan G ABRALDES

HPVG AS A GOLD STANDARD

Predictive factors of improvements in the prognoses after portosystemic shunt occlusion in portal hypertension patients

3 - Predictive factors of improvements in the prognoses after portosystemic shunt occlusion in portal hypertension patients


Tsuyoshi Ishikawa, Ryo Sasaki, Takuya Iwamoto, Taro Takami, Isao Sakaida

IMPACT OF THERAPIES

Incidence, predictors and outcomes of de novo non neoplastic portal vein thrombosis in hbd and hcv cirrhotics treated with antivirals

4 - Incidence, predictors and outcomes of de novo non neoplastic portal vein thrombosis in hbd and hcv cirrhotics treated with antivirals


Giulia Tosetti, Alessandro Loglio, Elisabetta Degasperi, Roberta D’Ambrosio, Vincenzo La Mura, MauroVigan, Massimo Iavaron, Marta Borgh, Roberta Soffredin, Floriana Facchetti, Smaragda Biluou, Maria Grazia Rumi, Massimo Primignani, Pietro Lampertico

IMPACT OF THERAPIES

Pediatric portal hypertension in the united states: a nationwide study 2004-2014

5 - Pediatric portal hypertension in the united states: a nationwide study 2004-2014


Paul Wasuwanich, Harjit Singh, Wikrom Karnsakul

IMPACT OF THERAPIES

Stratifying the risk of variceal bleeding in compensated liver disease at baseline by non-invasive tools. a decision curve analysis

6 - Stratifying the risk of variceal bleeding in compensated liver disease at baseline by non-invasive tools. a decision curve analysis


Sanchit Sharma, Samagra Agarwal, Ankur Jindal, Sushrut Singh, Rakesh Jagdish, Deepak Gunjan, Shiv Kumar Sarin, Anoop Saraya

NON INVASIVE SURROGATES

Unsedated ultrathin endoscopy for variceal surveillance in the outpatient setting – evidence into practice

7 - Unsedated ultrathin endoscopy for variceal surveillance in the outpatient setting – evidence into practice


Rohit Gupta, Ali Eqbal, Tehara Wickremeratne, Stephanie Turner, Jonathan Mitchell, James O'Beirne

NON INVASIVE SURROGATES

Real-world validation of ABP criteria in avoiding screening endoscopy among patients with compensated advanced chronic liver disease

8 - Real-world validation of ABP criteria in avoiding screening endoscopy among patients with compensated advanced chronic liver disease


M Putera, Kew GS , R Kumar, Ang TL, John Hsiang, Tan PS, Wong YJ

NON INVASIVE SURROGATES

Spleen stiffness measurement as non-invasive surrogate for esophageal varices in chronic liver disease ?

9 - Spleen stiffness measurement as non-invasive surrogate for esophageal varices in chronic liver disease ?


Pratap Sagar Tiwari, Sudhamshu KC

NON INVASIVE SURROGATES

Magnetically controlled capsule endoscopy for assessing varices in compensated advanced chronic liver disease (chess1801): a prospective multicentre study

10 - Magnetically controlled capsule endoscopy for assessing varices in compensated advanced chronic liver disease (chess1801): a prospective multicentre study


Xiaolong Qi, Shuai Wan, Weiling Hu, Hua Mao, Yanna Liu, Li Yang, Chunqing Zhang, Xiaorong Ma, Liting Zhang, Yifei Huang, Chaohui H, Ming Xu, Tong Dang, Bin Wu, Mark Edward McAlindon , Xavier Dray, Zhuan Liao

NON INVASIVE SURROGATES

Changes in spleen stiffness measurement in patients undergoing transjugular intrahepatic portosystemic shunt placement as assessed by transient elastography and shear-wave elastography

11 - Changes in spleen stiffness measurement in patients undergoing transjugular intrahepatic portosystemic shunt placement as assessed by transient elastography and shear-wave elastography


Amine Benmassaoud, Davide Roccarina, Evangelia Koutli, Emmanuel Tsochatzis

NON INVASIVE SURROGATES

Chess criteria for the screening of varices in patients with compensated advanced chronic liver disease: a multicenter study

12 - Chess criteria for the screening of varices in patients with compensated advanced chronic liver disease: a multicenter study


Xiaolong Qi, Chuan Liu, Xinwen Yan, Xiaoli Zhao, Hua Mao, Shuai Wang, Weiling Hu, Dengxiang Liu, Jitao Wang, Xiaoling Chi, Li Yang, Chaohui He, Liting Zhang, Xiaorong Mao, Dan Xu, Yifei Huang, Jia Li, Fengmei Wang

NON INVASIVE SURROGATES

Spleen shear wave elastography as marker of portal hypertension in patients with extrahepatic portal vein thrombosis

13 - Spleen shear wave elastography as marker of portal hypertension in patients with extrahepatic portal vein thrombosis


Giada Pallini , Davide Roccarina, Matteo Rosselli, Laura Iogna Prat, Mallika Sekhar, Jennifer Ryan, Massimo Pinzani, David Patch

NON INVASIVE SURROGATES

Risk factors of esophageal varices needing treatment

14 - Risk factors of esophageal varices needing treatment


Federico Ravaioli, Arthur Berger,Oana Farcau, Davide Festi, Horia Stefanescu, François Buisson, Pierre Nahon, Christophe Bureau, Nathalie Ganne-Carriè, Annalisa Berzigotti, Victor de Ledinghen, Salvatore Petta, Paul Calès

NON INVASIVE SURROGATES

The variscreen algorithm using successively platelets, liver stiffness and inr improves and secures the screening of esophageal varices needing treatment

15 - The variscreen algorithm using successively platelets, liver stiffness and inr improves and secures the screening of esophageal varices needing treatment


Federico Ravaioli, Arthur Berger,Oana Farcau, Davide Festi, Horia Stefanescu, François Buisson, Pierre Nahon, Christophe Bureau, Nathalie Ganne-Carriè, Annalisa Berzigotti, Victor de Ledinghen, Salvatore Petta, Paul Calès

NON INVASIVE SURROGATES

Assessment of baveno vi and expanded baveno vi criteria for screening and follow-up of small esophageal varices in patients with compensated viral cirrhosis (anrs/co12 cirvir cohort)

16 - Assessment of baveno vi and expanded baveno vi criteria for screening and follow-up of small esophageal varices in patients with compensated viral cirrhosis (anrs/co12 cirvir cohort)


Charlotte Bouzbib, Pierre Nahon, Richard Layese, Tarik Asselah, Dominique Guyader, Stanislas Pol, Etienne Audureau, Françoise Roudot-Thoraval, Dominique Thabut

NON INVASIVE SURROGATES

Assessment of expanded baveno vi criteria for screening and follow-up of large esophageal varices in patients with compensated viral cirrhosis (cirvir cohort)

17 - Assessment of expanded baveno vi criteria for screening and follow-up of large esophageal varices in patients with compensated viral cirrhosis (cirvir cohort)


Charlotte Bouzbib , Pierre Nahon, Richard Layese, Tarik Asselah, Dominique Guyader, Stanislas Pol, Etienne Audureau, Françoise Roudot-Thoraval, Dominique Thabut

NON INVASIVE SURROGATES

Assessment of baveno vi and expanded baveno vi criteria for screening and follow-up of large esophageal varices in patients with compensated alcoholrelated cirrhosis (cirral cohort)

18 - Assessment of baveno vi and expanded baveno vi criteria for screening and follow-up of large esophageal varices in patients with compensated alcoholrelated cirrhosis (cirral cohort)


Charlotte Bouzbib, Dominique Thabut, Cendrine Chaffaut, Sylvie Chevret, Nathalie Ganne-Carrié

NON INVASIVE SURROGATES

Liver stiffness after daa predicts outcome of hcv patients with compensated advanced chronic liver disease who achieved sustained virological response

19 - Liver stiffness after daa predicts outcome of hcv patients with compensated advanced chronic liver disease who achieved sustained virological response


Cristina Rigamonti, Stefano Fangazio, Alessandro Croce, Carla De Benedittis, Micol Cittone, Elisa Ceriani, Mattia Bellan, Rosalba Minisini, Mario Pirisi

NON INVASIVE SURROGATES

Ascites - harbringer of decompensating liver disease or transient phenomena in children and young adults with portal hypertension

20 - Ascites - harbringer of decompensating liver disease or transient phenomena in children and young adults with portal hypertension


Paul Wasuwanich, Ann O. Scheimann, Wikrom Karnsakul

NON INVASIVE SURROGATES

Circulating microbiome in cirrhosis does not predict portal hypertension

21 - Circulating microbiome in cirrhosis does not predict portal hypertension


Rolandas Gedgaudas, Jasmohan S Bajaj, Jurgita Skieceviciene, Greta Varkalaite, Gabija Jurkeviciute, Sigita Gelman, Irena Valantiene, Romanas Zykus, Andrius Pranculis, Corinna Bang, Andre Franke5, Christoph Schramm, Juozas Kupcinskas

NON INVASIVE SURROGATES

Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease

22 - Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease


Samagra Agarwal, Sanchit Sharma, Manoj Kumar, Shantan Venishetty, Ankit Bhardwaj, Deepak Gunjan, Anoop Saraya and Shiv Kumar Sarin

NON INVASIVE SURROGATES

Rifaximin alleviates endotoxemia and intestinal hyperpermeability with partially modified fecal microbiota in cirrhotic patients

23 - Rifaximin alleviates endotoxemia and intestinal hyperpermeability with partially modified fecal microbiota in cirrhotic patients


Kosuke Kaji, Soichiro Saikawa, Hiroaki Takaya, Tadashi Namisaki, Hitoshi Yoshiji

PREVENTION OF (FURTHER) DECOMPENSATION

Serum endotoxin activity is associated with sarcopenia in alcoholic cirrhotic patients

24 - Serum endotoxin activity is associated with sarcopenia in alcoholic cirrhotic patients


Tadashi Namisaki, Shinya Sato, Kosuke Kaji, Kei Moriya, and Hitoshi Yoshiji

PREVENTION OF (FURTHER) DECOMPENSATION

Efficacy and safety of intravenous albumin for nonspontaneous bacterial peritonitis infection among cirrhosis: systematic review and meta-analysis of randomised trials

25 - Efficacy and safety of intravenous albumin for nonspontaneous bacterial peritonitis infection among cirrhosis: systematic review and meta-analysis of randomised trials


Wong YJ , Mohan BP , Qiu TY , Tam YC , P. Angeli

PREVENTION OF (FURTHER) DECOMPENSATION

Rifaximin as first-line therapy for primary prophylaxis of spontaneous bacterial peritonitis among decompensated cirrhosis: network meta-analysis of randomised conrolled trials

26 - Rifaximin as first-line therapy for primary prophylaxis of spontaneous bacterial peritonitis among decompensated cirrhosis: network meta-analysis of randomised conrolled trials


Wong YJ, Y Wong, Tee CH, Lum HM, PH Thurairajah, Ang TL, Fock KM, Shi

PREVENTION OF (FURTHER) DECOMPENSATION

Effect of hepatic arterial buffer response induced by partial splenic embolization on hepatic function in cirrhotic patients by child-pugh classification

27 - Effect of hepatic arterial buffer response induced by partial splenic embolization on hepatic function in cirrhotic patients by child-pugh classification


Ryo Sasaki, Tsuyoshi Ishikawa, Takuya Iwamoto, Taro Takami, Isao Sakaida

PREVENTION OF (FURTHER) DECOMPENSATION

Midodrine improves the tolerability of diuretics in acute-on-chronic liver failure patients

28 - Midodrine improves the tolerability of diuretics in acute-on-chronic liver failure patients


Anand V. Kulkarni, Pramod Kumar, Mithun Sharma, Rajesh Gupta, D. Nageshwar Reddy, P N Rao

PREVENTION OF (FURTHER) DECOMPENSATION

Decompensation in dda cured hcv compensated patients with clinically significant portal hypertension: too rare to warrant universal b-blocker therapy

29 - Decompensation in dda cured hcv compensated patients with clinically significant portal hypertension: too rare to warrant universal b-blocker therapy


Tosetti Giulia, Degasperi Elisabetta, Farina Elisa, D’Ambrosio Roberta, Soffredini Roberta, Borghi Marta, La Mura Vincenzo, Primignani Massimo, Lampertico Pietro

PREVENTION OF (FURTHER) DECOMPENSATION

Preoperative tips prevents the development of post-operative acute-on-chronic liver failure in patients with high clif-c ad score

30 - Preoperative tips prevents the development of post-operative acute-on-chronic liver failure in patients with high clif-c ad score


Johannes Chang, Pauline Höfer, Nina Böhling, Philipp Lingohr, Steffen Manekeller, Jörg C. Kalff, Jonas Dohmen, Dominik J. Kaczmarek, Christian Jansen, Carsten Meyer, Christian P. Strassburg, Jonel Trebicka, Michael Praktiknjo

PREVENTION OF (FURTHER) DECOMPENSATION

Role of coagulopathy in salvage esophageal stent placement in acute severe variceal bleeding

31 - Role of coagulopathy in salvage esophageal stent placement in acute severe variceal bleeding


Joanna Ligocka, Slawomir Koziel, Jan Pertkiewicz, Michal Grat, Krzysztof Zieniewicz

VARICEAL BLEEDING

Upper gastrointestinal bleeding in patients with cirrhosis: beyond variceal bleeding.

32 - Upper gastrointestinal bleeding in patients with cirrhosis: beyond variceal bleeding.


Samonakis D, Demetriou G, Veniamin A, Orphanoudaki E, Mouzas I, Koulendaki M, Valatas V, Kalaitzakis E

VARICEAL BLEEDING

Prognosis of patients undergoing salvage tips for refractory variceal bleeding is still poor in the preemptive tips era

33 - Prognosis of patients undergoing salvage tips for refractory variceal bleeding is still poor in the preemptive tips era


Charlotte Bouzbib, Philippe Cluzel, Philippe Sultanik, Brigitte Bernard-Chabert, Julien Massard, Hedi Benosman, Maxime Mallet, Simona Tripon, Dominique Thabut, Marika Rudler

VARICEAL BLEEDING

Hemodynamic and liver stiffness changes after endoscopic variceal ligation: a cohort study

34 - Hemodynamic and liver stiffness changes after endoscopic variceal ligation: a cohort study


Nerea Gonzalo; Consuelo Froilán;Teresa Hernández; Yolanda Zarauza; Marta Abadía; Dolores Ponce; José Suárez; P. Mora

VARICEAL BLEEDING

Long-term observation in patients with esophageal varices after endoscopic variceal ligation accompanied with 24-hour ph monitoring

35 - Long-term observation in patients with esophageal varices after endoscopic variceal ligation accompanied with 24-hour ph monitoring


Hisashi Hidaka, Shigehiro Kokubu Satoshi Tanabe, Xue Shao, Naohisa Wada, Kousuke Kubota, Haruki Uojima, Yoshiaki Tanaka, Takahide Nakazawa, Akitaka Shibuya, Wasaburo Koizumi

VARICEAL BLEEDING

Outcomes after bleeding due to gastric varices

36 - Outcomes after bleeding due to gastric varices


Brett Fortune, Rochelle Wong, Adam Buckholz, Gaurav Ghosh, Wesley Rogers

VARICEAL BLEEDING

Risk factors and predictors for 6-week mortality in patients with variceal bleeding

37 - Risk factors and predictors for 6-week mortality in patients with variceal bleeding


Brett Fortune, Rochelle Wong, Adam Buckholz, Gaurav Ghosh, Wesley Rogers

VARICEAL BLEEDING

Comparison of cyanoacrylate glue therapy with and without lipiodol for treatment of acute gastric varceal bleeding

38 - Comparison of cyanoacrylate glue therapy with and without lipiodol for treatment of acute gastric varceal bleeding


Athidi G. Earasi, M.D., Zachary H. Henry, M.D

VARICEAL BLEEDING

Out-of-hours endoscopy: effectiveness of a single referral hospital model of care according to baveno vi criteria

39 - Out-of-hours endoscopy: effectiveness of a single referral hospital model of care according to baveno vi criteria


Joana Silva, Daniela Falcão, Tiago Guedes, Mónica Garrido, Marta Rocha, Luís Maia, Teresa Moreira, José Manuel Ferreira, Isabel Pedroto

VARICEAL BLEEDING

Is it necessary to transfuse fresh frozen plasma (ffp) and platelets before esophageal variceal band ligation in acute variceal bleeding patients? south east asia experience. rip ffp and platelets transfusion!

40 - Is it necessary to transfuse fresh frozen plasma (ffp) and platelets before esophageal variceal band ligation in acute variceal bleeding patients? south east asia experience. rip ffp and platelets transfusion!


Jalpa Devi, Amerta Bai, Muhammad Sadik Memon,Bushra Kadir ,Riaz Hussain Awan, Aijaz Jujh

VARICEAL BLEEDING

Clinical experience of application of danis stent for esophageal variceal hemorrhage

41 - Clinical experience of application of danis stent for esophageal variceal hemorrhage


S. B. Zhigalova, G.V. Manukyan, A.G. Shertsinger, R.A. Musin, T.S. Semenova, Ya.S. Bobyleva

VARICEAL BLEEDING

Anticoagulant treatment for portal vein thrombosisefficacy and safety

42 - Anticoagulant treatment for portal vein thrombosisefficacy and safety


Irina Girleanu, Anca Trifan, Andreea Teodorescu, Laura Huiban, Camelia Cojocariu, Oana Cristina Petrea, Ana Maria Singeap, Catalin Sfarti, Stefan Chiriac , Tudor Cuciureanu, Carol Stanciu

VASCULAR LIVER DISEASE

Natural course and clinical outcomes in patients with transient portal vein thrombosis and liver cirrhosis

43 - Natural course and clinical outcomes in patients with transient portal vein thrombosis and liver cirrhosis


Irina Girleanu, Anca Trifan, Andreea Teodorescu, Laura Huiban, Camelia Cojocariu, Oana Cristina Petrea, Ana Maria Singeap, Catalin Sfarti, Stefan Chiriac , Tudor Cuciureanu, Carol Stanciu

VASCULAR LIVER DISEASE

Sleen stiffness for evaluation of surgical shunt function in patients with extrahepatic portal vein obstruction

44 - Sleen stiffness for evaluation of surgical shunt function in patients with extrahepatic portal vein obstruction


Kitsenko E.A. , Fandeyev E.E. , Kryzhanovskaya E.Yu. , Lebezev V.M. , Kamalov Yu.R. , Kosakevich E.R.

VASCULAR LIVER DISEASE

Management of pregnancy in patients with extrahepatic portal vein obstruction and gastroesophageal varices

45 - Management of pregnancy in patients with extrahepatic portal vein obstruction and gastroesophageal varices


Kitsenko E.A., Gabrielyan A.R., Apresyan S.V., Manukyan G.V., Fandeyev E.E., Zhigalova S.B., Kryzhanovskaya E.Yu., Schyukina A.A.

VASCULAR LIVER DISEASE

Transjugular intrahepatic portosystemic shunt is an effective treatment for portal hypertension due to hepatic myeloid metaplasia and positively impacts the nutritional status

46 - Transjugular intrahepatic portosystemic shunt is an effective treatment for portal hypertension due to hepatic myeloid metaplasia and positively impacts the nutritional status


S. Aspite, S. Gitto, U. Arena, F. Campani, C. Campani, C. Di Bonaventura, G. Laffi, M. Citone, F. Fanelli, F. Marra, F. Vizzutti

VASCULAR LIVER DISEASE

Treatment strategy for portal vein thrombosis with liver cirrhosis in toranomon hospital (japan)

47 - Treatment strategy for portal vein thrombosis with liver cirrhosis in toranomon hospital (japan)


Shunichiro Fujiyama, Satoshi Saitoh, Fumitaka Suzuki, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada

VASCULAR LIVER DISEASE

Rex shunt in a developing country – is it possible?

48 - Rex shunt in a developing country – is it possible?


Riccardo Superina, Caroline Lemoine, Caroline Montagner Dias, Melina Utz Melere, Carolina Soares da Silva, Luiza Salgado Nader, Cristine Suzana Trein, Alex Finger Horbe, Matias Epifanio, Cristina Targa Ferreira

VASCULAR LIVER DISEASE

Noninvasive methods of predicting esophageal varices in children with intrahepatic portal hypertension according to child-pugh classification

49 - Noninvasive methods of predicting esophageal varices in children with intrahepatic portal hypertension according to child-pugh classification


Marina Rossato Adami, Carlos Oscar Kieling, Renata Rostirola Guedes, Sandra Maria Gonçalves Vieira

VASCULAR LIVER DISEASE

Mesorex bypass and portosystemic shunts: long term outcomes in pediatric portal hypertension

50 - Mesorex bypass and portosystemic shunts: long term outcomes in pediatric portal hypertension


M.I. Rodriguez-Davalos, F. Lopez-Verdugo, Z. Kastenberg, J. Merola, A. Bertacco, A.S. Muñoz-Abraham, D. Alonso, W.R. Hewitt, M. Facciuto, S. Emre

VASCULAR LIVER DISEASE

Contemporary management of venous complications after liver transplantation

51 - Contemporary management of venous complications after liver transplantation


M.I. Rodriguez-Davalos, J. Sanchez-García, F. Lopez-Verdugo, P.G. Feola, C. Heyrend, M. Kavan, L. Book, M. Jepperson, I. Zendejas, A. Gagnon, D. Alonso, E. R. Scaife, S. Fujita, R. Gilroy

VASCULAR LIVER DISEASE

Frequency and risk factors for early fundal variceal rebleeding at mohamed salih idrees (msi) bleeding center, ibn sin hospital, khartoum ,sudan

52 - Frequency and risk factors for early fundal variceal rebleeding at mohamed salih idrees (msi) bleeding center, ibn sin hospital, khartoum ,sudan


Afraa Abu Baker, Dr Salma Barakat, FRCP

VARICEAL BLEEDING